New Enterprise Associates related stories
All articles and analysis
VC-backed SetPoint Medical taps Bevirt as clinical affairs VPSanta Clarita, California-based SetPoint Medical, a developer of bioelectronic therapy for chronic inflammatory diseases, has named Terry Bevirt as vice president of clinical affairs. Previously, Bevirt worked at Armagen where she served as senior director and head of clinical operations. SetPoint Medical's backers included Morgenthaler Ventures, New Enterprise Associates, Topspin Partners, Medtronic, GlaxoSmithKline’s Action Potential Venture Capital Limited and Boston Scientific.
- IonQ collects $20 mln Series B in NEA and GV-led round
Maryland-based IonQ, a developer of quantum computing for commercial applications, has closed $20 million in Series B round. New Enterprise Associates and GV led the round.
- Complexa lands $62 mln Series C
Pennsylvania-based Complexa Inc, a clinical stage biopharmaceutical company, has closed $62 million in Series C funding. New Enterprise Associates and Pfizer Venture Investments LLC led the round with participation from other investors that included Edmond de Rothschild Investment Partners and HBM Healthcare Investments.
- Language learning platform Duolingo scores $25 mln Series E
Duolingo, a language learning platform, has secured $25 million in Series E funding. Drive Capital led the round. The capital will be used to accelerate Duolingo's hiring and production development plans.
- NEA leads $50.5 mln Series C round in Trevi Therapeutics
New Enterprise Associates led a $50.5 million Series C funding round in late-stage clinical development company Trevi Therapeutics, Inc. Other investors in the funding round include Lundbeckfonden Ventures, Omega Funds and Aperture Venture Partners, along with the company's largest investor, TPG Biotech.
